Position in MRK
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,916,950
+$101,924 QoQ
Shares Held
22,700
-3.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,357
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Callahan Advisors, LLC holds $70,085,621 across 7 Drug Manufacturers - General names. MRK ranks #4 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
106,466 | $27,039,170 | |
| 2 | LLY |
ELI LILLY & Co
|
21,791 | $26,136,781 | |
| 3 | PFE |
Pfizer Inc
|
471,052 | $11,342,932 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
22,700 | $2,916,950 | |
| 5 | ABBV |
AbbVie Inc.
|
5,488 | $1,381,000 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,089 | $869,428 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,161 | $399,360 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,916,950 | 22,700 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,815,026 | 23,402 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,463,294 | 23,402 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,007,353 | 23,917 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $2,065,284 | 26,090 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $2,400,002 | 26,738 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $2,749,229 | 27,636 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $3,416,452 | 30,085 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $3,736,036 | 30,178 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $4,036,086 | 30,588 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $3,333,940 | 30,581 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $3,147,490 | 30,573 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $3,345,848 | 28,996 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $3,119,780 | 29,324 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $3,252,610 | 29,316 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $2,523,918 | 29,307 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,672,101 | 29,309 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $2,405,706 | 29,320 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $1,950,334 | 25,448 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,760,503 | 23,439 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $428,357 | 5,508 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $281,687 | 3,654 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $298,160 | 3,645 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $312,058 | 3,762 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $267,020 | 3,453 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $280,215 | 3,642 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||